Providence cancer spinoff charges ahead with immunotheapy drugs
Since Agonox did a deal with an AstraZeneca, the company has moved into new areas of research.
More here:
Providence cancer spinoff charges ahead with immunotheapy drugs
Since Agonox did a deal with an AstraZeneca, the company has moved into new areas of research.
More here:
Providence cancer spinoff charges ahead with immunotheapy drugs